Status:
COMPLETED
Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy
Lead Sponsor:
National Science and Technology Council, Taiwan
Conditions:
Depressive Disorder
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Whether high-dose omega-3 fatty acids supplement would be an effective treatment in patients with major depressive disorder during pregnancy and breast-feeding.
Eligibility Criteria
Inclusion
- Eligible participants were pregnant women, aged 18 to 40 years, with major depressive disorder onset between their 16th week (second trimester) and 32nd week (third trimester) of gestation at the Department of Obstetrics.
Exclusion
- Subjects were excluded with a DSM-IV diagnosis of bipolar disorders, psychotic disorders, substance abuse or dependence for at least 3 months, or any Axis-II diagnosis of borderline or antisocial personality disorder.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00618865
Start Date
June 1 2004
End Date
June 1 2004
Last Update
February 20 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.